PPBT – purple biotech ltd. - american depositary shares (US:NASDAQ)

News

Purple Biotech (PPBT) was upgraded by Zacks Research from "strong sell" to "hold".
Purple Biotech Announces AI Collaboration with Converge Bio to Accelerate Development of its Next-Generation Tri-Specific Antibody Platform
Yahoo Finance [Yahoo! Finance]
Purple Biotech Regains Compliance with Nasdaq
Purple Biotech (PPBT) was downgraded by Zacks Research from "hold" to "strong sell".
Show more
Live Event: Join our next subscriber-only event: "The Data Driven Investor"
Register for our next upcoming LIVE training session, which will be hosted on Tuesday April 24th at 08:00 PM EST (New York Time).
Get your questions answered during the Q & A session.
For any support questions, contact our team: support@newsquantified.com